Literature DB >> 30663638

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies.

Xin Xia1, Haitang Li2, Sangeetha Satheesan3, Jiehua Zhou2, John J Rossi2.   

Abstract

Ethical regulations and technical challenges for research in human pathology, immunology, and therapeutic development have placed small animal models in high demand. With a close genetic and behavioral resemblance to humans, small animals such as the mouse are good candidates for human disease models, through which human-like symptoms and responses can be recapitulated. Further, the mouse genetic background can be altered to accommodate diverse demands. The NOD/SCID/IL2rγnull (NSG) mouse is one of the most widely used immunocompromised mouse strains; it allows engraftment with human hematopoietic stem cells and/or human tissues and the subsequent development of a functional human immune system. This is a critical milestone in understanding the prognosis and pathophysiology of human-specific diseases such as HIV/AIDS and aiding the search for a cure. Herein, we report a detailed protocol for generating a humanized NSG mouse model (hu-NSG) by hematopoietic stem cell transplantation into a radiation-conditioned neonatal NSG mouse. The hu-NSG mouse model shows multi-lineage development of transplanted human stem cells and susceptibility to HIV-1 viral infection. It also recapitulates key biological characteristics in response to combinatorial antiretroviral therapy (cART).

Entities:  

Mesh:

Year:  2019        PMID: 30663638      PMCID: PMC6559246          DOI: 10.3791/58255

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  40 in total

1.  HIV latency in the humanized BLT mouse.

Authors:  Matthew D Marsden; Michael Kovochich; Nuttee Suree; Saki Shimizu; Roshni Mehta; Ruth Cortado; Gregory Bristol; Dong Sung An; Jerome A Zack
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Experimental approaches to the study of HIV-1 latency.

Authors:  Yefei Han; Megan Wind-Rotolo; Hung-Chih Yang; Janet D Siliciano; Robert F Siliciano
Journal:  Nat Rev Microbiol       Date:  2007-02       Impact factor: 60.633

3.  Isolation and propagation of HIV-1 on peripheral blood mononuclear cells.

Authors:  Angélique B van 't Wout; Hanneke Schuitemaker; Neeltje A Kootstra
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

4.  Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation.

Authors:  Ping Lan; Noriko Tonomura; Akira Shimizu; Shumei Wang; Yong-Guang Yang
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

5.  Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity.

Authors:  Jiehua Zhou; Sangeetha Satheesan; Haitang Li; Marc S Weinberg; Kevin V Morris; John C Burnett; John J Rossi
Journal:  Chem Biol       Date:  2015-03-05

Review 6.  Humanized mice for immune system investigation: progress, promise and challenges.

Authors:  Leonard D Shultz; Michael A Brehm; J Victor Garcia-Martinez; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

7.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

8.  The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).

Authors:  Yohei Watanabe; Takeshi Takahashi; Akira Okajima; Miho Shiokawa; Naoto Ishii; Ikumi Katano; Ryoji Ito; Mamoru Ito; Masayoshi Minegishi; Naoko Minegishi; Shigeru Tsuchiya; Kazuo Sugamura
Journal:  Int Immunol       Date:  2009-06-10       Impact factor: 4.823

9.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.

Authors:  J M McCune; R Namikawa; H Kaneshima; L D Shultz; M Lieberman; I L Weissman
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

10.  Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex.

Authors:  M A King; L Covassin; M A Brehm; W Racki; T Pearson; J Leif; J Laning; W Fodor; O Foreman; L Burzenski; T H Chase; B Gott; A A Rossini; R Bortell; L D Shultz; D L Greiner
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

View more
  3 in total

1.  Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity.

Authors:  Dayson Moreira; Sagus Sampath; Haejung Won; Seok Voon White; Yu-Lin Su; Marice Alcantara; Chongkai Wang; Peter Lee; Ellie Maghami; Erminia Massarelli; Marcin Kortylewski
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

2.  Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade.

Authors:  Fei Ju; Yong Luo; Chaolong Lin; Xian Jia; Zilong Xu; Rui Tian; Yanhua Lin; Min Zhao; Yating Chang; Xiaoxuan Huang; Shaopeng Li; Wenfeng Ren; Yaning Qin; Mengqin Yu; Jizong Jia; Jinle Han; Wenxin Luo; Jun Zhang; Guo Fu; Xiangzhong Ye; Chenghao Huang; Ningshao Xia
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

Review 3.  HLA-G and humanized mouse models as a novel therapeutic approach in transplantation.

Authors:  Ashwin Ajith; Vera Portik-Dobos; Daniel D Horuzsko; Rajan Kapoor; Laura L Mulloy; Anatolij Horuzsko
Journal:  Hum Immunol       Date:  2020-02-21       Impact factor: 2.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.